Steris (STE) Profit After Tax Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 30.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.30% |
| Dec 31, 2025 | 11.99% |
| Sep 30, 2025 | 26.92% |
| Jun 30, 2025 | 22.42% |
| Mar 31, 2025 | 15,207.19% |
| Dec 31, 2024 | 23.27% |
| Sep 30, 2024 | 31.11% |
| Jun 30, 2024 | 11.35% |
| Mar 31, 2024 | -100.55% |
| Dec 31, 2023 | 14.12% |
| Sep 30, 2023 | 136.58% |
| Jun 30, 2023 | 17.90% |
| Mar 31, 2023 | 248.63% |
| Dec 31, 2022 | -13.82% |
| Sep 30, 2022 | -551.55% |
| Jun 30, 2022 | 607.89% |
| Mar 31, 2022 | -40.23% |
| Dec 31, 2021 | 24.97% |
| Sep 30, 2021 | -34.05% |
| Jun 30, 2021 | -124.34% |
| Mar 31, 2021 | -28.67% |
| Dec 31, 2020 | 9.12% |
| Sep 30, 2020 | 11.70% |
| Jun 30, 2020 | 4.95% |
| Mar 31, 2020 | 12.73% |
| Dec 31, 2019 | 119.25% |
| Sep 30, 2019 | 22.35% |
| Jun 30, 2019 | 21.97% |
| Mar 31, 2019 | 47.76% |